References
- Shan JL, Dai N, Yang XQ, et al. FokI polymorphism in vitamin D receptor gene and risk of breast cancer among Caucasian women. Tumour Biol 2014;35:3503–8
- Richetta AG, Silvestri V, Giancristoforo S, et al. A-1012G promoter polymorphism of vitamin D receptor gene is associated with psoriasis risk and lower allele-specific expression. DNA Cell Biol 2014;33:102–9
- Engel LS, Satagopan J, Sima CS, et al. Sun exposure, vitamin D receptor genetic variants, and risk of breast cancer in the Agricultural Health Study. Environ Health Perspect 2014;122:165–71
- Li YJ, Tang YW, Shi YQ, et al. Polymorphisms in the vitamin D receptor gene and risk of primary biliary cirrhosis: a meta-analysis. J Gastroenterol Hepatol 2014;29:706–15
- Saad K, Elsayh KI, Zahran AM, et al. Lymphocyte populations and apoptosis of peripheral blood B and T lymphocytes in children with end stage renal disease. Ren Fail 2014;36:502–7
- Mousavi SS, Soleimani A, Mousavi MB. Epidemiology of end-stage renal disease in Iran: a review article. Saudi J Kidney Dis Transpl 2014;25:697–702
- Graciano AJ, Chone CT, Fischer CA. Applicability of immediate, late or serial intact parathyroid hormone measurement following total thyroidectomy. Braz J Otorhinolaryngol 2012;78:78–82
- Qin YH, Zhou TB, Su LN, et al. Association between ACE polymorphism and risk of IgA nephropathy: a meta-analysis. J Renin Angiotensin Aldosterone Syst 2011;12:215–23
- Zhou TB, Drummen GP, Jiang ZP, et al. GSTT1 Polymorphism and the Risk of Developing Prostate Cancer. Am J Epidemiol 2014;180:1–10
- Zhou TB, Liu YG, Lin N, et al. Relationship between angiotensin-converting enzyme insertion/deletion gene polymorphism and systemic lupus erythematosus/lupus nephritis: a systematic review and metaanalysis. J Rheumatol 2012;39:686–93
- Zhou TB, Ou C, Qin YH, et al. Association of angiotensin converting enzyme insertion/deletion gene polymorphism with idiopathic nephrotic syndrome susceptibility in children: a meta-analysis. J Renin Angiotensin Aldosterone Syst 2011;12:601–10
- Zhou TB, Qin YH, Su LN, et al. The association between angiotensin-converting enzyme insertion/deletion gene variant and risk of focal segmental glomerulosclerosis: a systematic review and meta-analysis. J Renin Angiotensin Aldosterone Syst 2011;12:624–33
- Zhou TB, Yin SS, Jiang ZP. Association of angiotensin II type-1 receptor A1166C gene polymorphism with the susceptibility of end-stage renal disease. J Recept Signal Transduct Res 2013;33:325–31
- Zhou TB, Yin SS, Liang R. A meta-analysis of the association between angiotensin-converting enzyme insertion/deletion gene polymorphism and end-stage renal disease risk in IgA nephropathy patients. J Renin Angiotensin Aldosterone Syst 2013;14:235–41
- Zhou TB, Yin SS, Qin YH. Association of angiotensinogen M235T gene polymorphism with end-stage renal disease risk: a meta-analysis. Mol Biol Rep 2013;40:765–72
- Akiba T, Ando R, Kurihara S, et al. Is the bone mass of hemodialysis patients genetically determined? Kidney Int Suppl 1997;62:S69–71
- Karkoszka H, Chudek J, Strzelczyk P, et al. Does the vitamin D receptor genotype predict bone mineral loss in haemodialysed patients? Nephrol Dial Transplant 1998;13:2077–80
- Torregrosa JV, Ybarra J, Moreno A, et al. Vitamin D receptor gene polymorphisms and bone mineral density in patients on hemodialysis. Nephron 2000;84:381–2
- Marco MP, Craver L, Betriu A, et al. Influence of vitamin D receptor gene polymorphisms on mortality risk in hemodialysis patients. Am J Kidney Dis 2001;38:965–74
- Erturk S, Kutlay S, Karabulut HG, et al. The impact of vitamin D receptor genotype on the management of anemia in hemodialysis patients. Am J Kidney Dis 2002;40:816–23
- El-Shehaby AM, El-Khatib MM, Marzouk S, et al. Relationship of BsmI polymorphism of vitamin D receptor gene with left ventricular hypertrophy and atherosclerosis in hemodialysis patients. Scand J Clin Lab Invest 2013;73:75–81